Which has better earnings & valuation, GH or NTRA?

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Guardant Health $982.02M 21.94 -$416.28M -$3.39 N/A Natera $2.31B 17.08 -$208.16M -$1.63 N/A

Is GH or NTRA more profitable?

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Natera's return on equity. Company Net Margins Return on Equity Return on Assets Guardant Health -40.10% N/A -26.42% Natera -9.05% -14.74% -10.27%

Does the media prefer GH or NTRA?

In the previous week, Guardant Health had 4 more articles in the media than Natera. MarketBeat recorded 15 mentions for Guardant Health and 11 mentions for Natera. Guardant Health's average media sentiment score of 1.15 beat Natera's score of 0.77 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 6 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Natera 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BTSG or GH?

In the previous week, BrightSpring Health Services had 2 more articles in the media than Guardant Health. MarketBeat recorded 17 mentions for BrightSpring Health Services and 15 mentions for Guardant Health. Guardant Health's average media sentiment score of 1.15 beat BrightSpring Health Services' score of 0.19 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 4 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Guardant Health 6 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer FMS or GH?

In the previous week, Guardant Health had 11 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 15 mentions for Guardant Health and 4 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.30 beat Guardant Health's score of 1.15 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 6 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to GH or HIMS?

In the previous week, Guardant Health had 2 more articles in the media than Hims & Hers Health. MarketBeat recorded 15 mentions for Guardant Health and 13 mentions for Hims & Hers Health. Guardant Health's average media sentiment score of 1.15 beat Hims & Hers Health's score of 0.63 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 6 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 7 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Which has preferable valuation and earnings, GH or PACS?

PACS Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Guardant Health $982.02M 21.94 -$416.28M -$3.39 N/A PACS Group $5.29B 1.29 $191.54M $1.56 27.66

Does the media refer more to GH or PACS?

In the previous week, Guardant Health had 2 more articles in the media than PACS Group. MarketBeat recorded 15 mentions for Guardant Health and 13 mentions for PACS Group. Guardant Health's average media sentiment score of 1.15 beat PACS Group's score of 0.07 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 6 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 3 Very Positive mention(s) 7 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Guardant Health (GH) Competitors

$160.81 +2.41 (+1.52%)

As of 10:58 AM Eastern

Compare

GH vs. NTRA, BTSG, FMS, HIMS, and PACS

Should you buy Guardant Health stock or one of its competitors? MarketBeat compares Guardant Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Guardant Health include Natera (NTRA), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

How does Guardant Health compare to Natera?

Guardant Health (NASDAQ:GH) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

In the previous week, Guardant Health had 4 more articles in the media than Natera. MarketBeat recorded 15 mentions for Guardant Health and 11 mentions for Natera. Guardant Health's average media sentiment score of 1.15 beat Natera's score of 0.77 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	6 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Natera	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Guardant Health currently has a consensus price target of $158.74, suggesting a potential downside of 2.29%. Natera has a consensus price target of $267.83, suggesting a potential downside of 2.64%. Given Guardant Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe Guardant Health is more favorable than Natera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
Natera	1 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	3 Strong Buy rating(s)	2.86

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 5.6% of Guardant Health shares are held by insiders. Comparatively, 5.1% of Natera shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	21.94	-$416.28M	-$3.39	N/A
Natera	$2.31B	17.08	-$208.16M	-$1.63	N/A

Guardant Health has a beta of 1.59, suggesting that its share price is 59% more volatile than the broader market. Comparatively, Natera has a beta of 1.51, suggesting that its share price is 51% more volatile than the broader market.

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
Natera	-9.05%	-14.74%	-10.27%

Summary

Guardant Health beats Natera on 10 of the 17 factors compared between the two stocks.

How does Guardant Health compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Guardant Health (NASDAQ:GH) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.

BrightSpring Health Services has a beta of 1.79, suggesting that its share price is 79% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.59, suggesting that its share price is 59% more volatile than the broader market.

BrightSpring Health Services currently has a consensus price target of $70.12, suggesting a potential downside of 0.17%. Guardant Health has a consensus price target of $158.74, suggesting a potential downside of 2.29%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, research analysts plainly believe BrightSpring Health Services is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	1 Hold rating(s)	18 Buy rating(s)	1 Strong Buy rating(s)	3.00
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96

BrightSpring Health Services has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$12.91B	1.07	$190.67M	$1.41	49.81
Guardant Health	$982.02M	21.94	-$416.28M	-$3.39	N/A

BrightSpring Health Services has a net margin of 2.27% compared to Guardant Health's net margin of -40.10%. BrightSpring Health Services' return on equity of 14.63% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.27%	14.63%	4.41%
Guardant Health	-40.10%	N/A	-26.42%

92.6% of Guardant Health shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by company insiders. Comparatively, 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, BrightSpring Health Services had 2 more articles in the media than Guardant Health. MarketBeat recorded 17 mentions for BrightSpring Health Services and 15 mentions for Guardant Health. Guardant Health's average media sentiment score of 1.15 beat BrightSpring Health Services' score of 0.19 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	4 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Guardant Health	6 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

BrightSpring Health Services beats Guardant Health on 11 of the 16 factors compared between the two stocks.

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Guardant Health (NASDAQ:GH) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk, media sentiment and institutional ownership.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.59	$1.11B	$1.90	12.80
Guardant Health	$982.02M	21.94	-$416.28M	-$3.39	N/A

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 5.6% of Guardant Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Guardant Health's net margin of -40.10%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%
Guardant Health	-40.10%	N/A	-26.42%

In the previous week, Guardant Health had 11 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 15 mentions for Guardant Health and 4 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.30 beat Guardant Health's score of 1.15 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardant Health	6 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $28.00, indicating a potential upside of 15.09%. Guardant Health has a consensus price target of $158.74, indicating a potential downside of 2.29%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, equities analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.56
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96

Fresenius Medical Care AG & Co. KGaA has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market. Comparatively, Guardant Health has a beta of 1.59, meaning that its share price is 59% more volatile than the broader market.

Summary

Fresenius Medical Care AG & Co. KGaA beats Guardant Health on 9 of the 17 factors compared between the two stocks.

How does Guardant Health compare to Hims & Hers Health?

Guardant Health (NASDAQ:GH) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

Guardant Health has a beta of 1.59, meaning that its stock price is 59% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.35, meaning that its stock price is 135% more volatile than the broader market.

In the previous week, Guardant Health had 2 more articles in the media than Hims & Hers Health. MarketBeat recorded 15 mentions for Guardant Health and 13 mentions for Hims & Hers Health. Guardant Health's average media sentiment score of 1.15 beat Hims & Hers Health's score of 0.63 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	6 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	7 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Hims & Hers Health has a net margin of -0.56% compared to Guardant Health's net margin of -40.10%. Hims & Hers Health's return on equity of 6.10% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
Hims & Hers Health	-0.56%	6.10%	1.52%

Hims & Hers Health has higher revenue and earnings than Guardant Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	21.94	-$416.28M	-$3.39	N/A
Hims & Hers Health	$2.35B	3.48	$128.37M	-$0.09	N/A

Guardant Health currently has a consensus price target of $158.74, suggesting a potential downside of 2.29%. Hims & Hers Health has a consensus price target of $30.70, suggesting a potential downside of 13.05%. Given Guardant Health's stronger consensus rating and higher possible upside, equities research analysts plainly believe Guardant Health is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 5.6% of Guardant Health shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Guardant Health beats Hims & Hers Health on 9 of the 17 factors compared between the two stocks.

How does Guardant Health compare to PACS Group?

Guardant Health (NASDAQ:GH) and PACS Group (NYSE:PACS) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk.

Guardant Health presently has a consensus price target of $158.74, indicating a potential downside of 2.29%. PACS Group has a consensus price target of $50.60, indicating a potential upside of 17.29%. Given PACS Group's higher probable upside, analysts clearly believe PACS Group is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Guardant Health has a beta of 1.59, indicating that its share price is 59% more volatile than the broader market. Comparatively, PACS Group has a beta of -0.08, indicating that its share price is 108% less volatile than the broader market.

92.6% of Guardant Health shares are held by institutional investors. 5.6% of Guardant Health shares are held by company insiders. Comparatively, 70.1% of PACS Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Guardant Health had 2 more articles in the media than PACS Group. MarketBeat recorded 15 mentions for Guardant Health and 13 mentions for PACS Group. Guardant Health's average media sentiment score of 1.15 beat PACS Group's score of 0.07 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	6 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	3 Very Positive mention(s)	7 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PACS Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	21.94	-$416.28M	-$3.39	N/A
PACS Group	$5.29B	1.29	$191.54M	$1.56	27.66

PACS Group has a net margin of 4.49% compared to Guardant Health's net margin of -40.10%. PACS Group's return on equity of 26.47% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
PACS Group	4.49%	26.47%	4.36%

Summary

PACS Group beats Guardant Health on 9 of the 17 factors compared between the two stocks.

Get Guardant Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GH vs. The Competition

Export

Metric	Guardant Health	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$21.37B	$3.71B	$7.05B	$12.61B
Dividend Yield	N/A	2.20%	2.68%	8.00%
P/E Ratio	-47.54	20.85	27.10	24.26
Price / Sales	21.94	314.01	588.85	117.88
Price / Cash	N/A	61.98	29.22	49.36
Price / Book	-205.65	8.49	10.85	6.29
Net Income	-$416.28M	$23.83M	$3.58B	$330.66M
7 Day Performance	-0.28%	-3.56%	-2.12%	-1.35%
1 Month Performance	23.44%	6.31%	3.27%	-0.64%
1 Year Performance	226.43%	48.30%	26.33%	19.08%

Guardant Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GH Guardant Health	2.8181 of 5 stars	$160.81 +1.5%	$158.74 -1.3%	+215.2%	$21.31B	$982.02M	N/A	2,506	News Coverage Positive News Analyst Forecast
NTRA Natera	2.2085 of 5 stars	$283.80 +1.6%	$262.00 -7.7%	+70.1%	$40.00B	$2.31B	N/A	6,140	Analyst Forecast
BTSG BrightSpring Health Services	2.5777 of 5 stars	$70.56 +2.2%	$63.67 -9.8%	+242.9%	$13.62B	$12.91B	55.67	23,500	Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	4.2093 of 5 stars	$23.62 +0.4%	$28.00 +18.5%	-9.6%	$12.64B	$22.20B	12.43	1,488	Positive News
HIMS Hims & Hers Health	3.2282 of 5 stars	$38.34 +4.2%	$30.63 -20.1%	-28.2%	$8.52B	$2.35B	N/A	2,442

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GH) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Guardant Health (GH) Competitors

GH vs. NTRA, BTSG, FMS, HIMS, and PACS

How does Guardant Health compare to Natera?

Summary

How does Guardant Health compare to BrightSpring Health Services?

Summary

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Guardant Health compare to Hims & Hers Health?

Summary

How does Guardant Health compare to PACS Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GH vs. The Competition

Guardant Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Guardant Health (GH) Competitors

GH vs. NTRA, BTSG, FMS, HIMS, and PACS

How does Guardant Health compare to Natera?

Does the media prefer GH or NTRA?

Do analysts recommend GH or NTRA?

Do insiders & institutionals believe in GH or NTRA?

Which has better earnings & valuation, GH or NTRA?

Which has more volatility & risk, GH or NTRA?

Is GH or NTRA more profitable?

Summary

How does Guardant Health compare to BrightSpring Health Services?

Which has more volatility and risk, BTSG or GH?

Do analysts recommend BTSG or GH?

Which has stronger valuation and earnings, BTSG or GH?

Is BTSG or GH more profitable?

Do institutionals and insiders hold more shares of BTSG or GH?

Does the media favor BTSG or GH?

Summary

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Which has stronger earnings and valuation, FMS or GH?

Do insiders & institutionals have more ownership in FMS or GH?

Is FMS or GH more profitable?

Does the media prefer FMS or GH?

Do analysts prefer FMS or GH?

Which has more volatility & risk, FMS or GH?

Summary

How does Guardant Health compare to Hims & Hers Health?

Which has more volatility and risk, GH or HIMS?

Does the media refer more to GH or HIMS?

Is GH or HIMS more profitable?

Which has stronger valuation and earnings, GH or HIMS?

Do analysts recommend GH or HIMS?

Do institutionals and insiders hold more shares of GH or HIMS?

Summary

How does Guardant Health compare to PACS Group?

Do analysts rate GH or PACS?

Which has more risk and volatility, GH or PACS?

Do institutionals & insiders believe in GH or PACS?

Does the media refer more to GH or PACS?

Which has preferable valuation and earnings, GH or PACS?

Is GH or PACS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GH vs. The Competition

Guardant Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools